Ambrx Biopharma Inc.
Ambrx Biopharma Inc.（AMAM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
amam · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2025年4月25日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Hold
6 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $28.00
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $28.00 | ↑ 0.01% |
1-day model range: $27.99–$28.01. Peak: $28.01 (+0.01%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AMAM · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-01-16 | Baird | Downgrade ↓ | Outperform→Neutral |
| 2024-01-10 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2024-01-09 | B. Riley Securities | Downgrade ↓ | Buy→Neutral |
| 2023-11-29 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-11-20 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-11-15 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2023-11-14 | RBC Capital | Maintains | Outperform→Outperform |
| 2023-10-23 | RBC Capital | Maintains | Outperform→Outperform |
| 2023-10-23 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-09-18 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Ambrx Biopharma Inc. (AMAM) stock. Of the recent 22 rating actions, 0 were upgrades and 3 were downgrades. 6 analysts currently cover AMAM.
分析师推荐趋势
AMAM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4M
↓ 3.6% YoY
Revenue Next Year
$6M
↑ 40.9% YoY
EPS This Year
$0.07
EPS Next Year
$-0.19
↓ 373.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast AMAM EPS of $0.07 for the current fiscal year, based on estimates from 1 analysts. The AMAM revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AMAM 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AMAM 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。
AMAM 的短期预测（明日）为 $28.00（+0.01%）。
Ambrx Biopharma Inc. 在 NYSE 上市，代码 AMAM。AMAM 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 33% 对应 Hold 共识。
常见问题
AMAM 预测 · 8 个问题根据 6 位华尔街分析师，AMAM 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $28.00，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.